Unlock instant, AI-driven research and patent intelligence for your innovation.

Medicine for treating AD (alzheimer's disease) and preparation method thereof

A technology for Alzheimer's disease and drugs, applied in the field of new drug delivery systems of traditional Chinese medicine, can solve problems such as large toxic and side effects and poor treatment effect, and achieve great application potential, improve treatment effect, and enhance the effect of curative effect.

Inactive Publication Date: 2018-09-04
CHENGDU UNIV
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The purpose of the present invention is to provide a drug for the treatment of Alzheimer's disease and a preparation method thereof, aiming at being safer and more effective, in view of the shortcomings of the currently clinically used drugs for the treatment of AD, such as poor therapeutic effect and large toxic and side effects. Effective multi-target intervention therapy for AD to improve the quality of life of AD patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating AD (alzheimer's disease) and preparation method thereof
  • Medicine for treating AD (alzheimer's disease) and preparation method thereof
  • Medicine for treating AD (alzheimer's disease) and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] TC@PLGA / NPs nanoparticles were prepared by the ultrasonic-assisted emulsifier evaporation method in the one-step method. Take 5 mg of TanIIA and CTan and 150 mg of PLGA and dissolve them in 10 ml of dichloromethane to obtain an oil phase solution. Take 1 ml of the oil phase and dilute with 2- Slowly drop 3 drops / s into 15ml of 1.5% PVA aqueous phase solution, sonicate with ice bath probe for 8min (over 3s, stop for 5s). Stir for 2 hours to completely evaporate the organic solvent, centrifuge at 13,000 rpm for 30 minutes, collect drug-loaded nanoparticles, add PBS to wash, resuspend and centrifuge, repeat the operation twice, and freeze-dry for 5 hours under vacuum to obtain TC@PLGA / NPs. Store at ℃.

[0030] Take 40mg of borneol raw material, put it in a 10ml volumetric flask, and dissolve it with absolute ethanol to obtain a 4mg / ml borneol ethanol solution. At the same time, take 10mg of TC@PLGA / NPs, put it in a 10ml volumetric flask, and dissolve it with distilled wate...

Embodiment 2

[0032] TC@PLGA / NPs nanoparticles were prepared by the ultrasonic-assisted emulsifier evaporation method in the one-step method. Take 10 mg of TanIIA and CTan and 200 mg of PLGA and dissolve them in 10 ml of dichloromethane to obtain an oil phase solution. Take 1 ml of the oil phase and add 2- Slowly drop 3 drops / s into 10ml 2% PVA aqueous solution, sonicate with ice bath probe for 6min (over 3s, stop for 5s). 2h, let the organic solvent evaporate completely, centrifuge at 13000rpm for 30min, collect the drug-loaded nanoparticles, add PBS to wash, resuspend and centrifuge, repeat the operation twice, freeze-dry under vacuum for 5h, get TC@PLGA / NPs, store at 4°C .

[0033] Take 40mg of borneol raw material, put it in a 10ml volumetric flask, and dissolve it with absolute ethanol to obtain a 4mg / ml borneol ethanol solution. At the same time, take 10mg of TC@PLGA / NPs, put it in a 10ml volumetric flask, and dissolve it with distilled water to get For the drug-loaded nanosuspension...

Embodiment 3

[0035] TC@PLGA / NPs nanoparticles were prepared by the ultrasonic-assisted emulsifier evaporation method in the one-step method. Take 10 mg of TanIIA and CTan and 200 mg of PLGA and dissolve them in 10 ml of dichloromethane to obtain an oil phase solution. Take 1 ml of the oil phase and add 2- Slowly drop 3 drops / s into 10ml of 1% PVA aqueous phase solution, sonicate with ice bath probe for 5min (over 3s, stop for 5s). The solvent was completely evaporated, centrifuged at 13000rpm for 30min, collected drug-loaded nanoparticles, added PBS to wash, resuspended and centrifuged, repeated twice, and freeze-dried for 5h under vacuum to obtain TC@PLGA / NPs, which were stored at 4°C.

[0036] Take 40mg of borneol raw material, put it in a 10ml volumetric flask, and dissolve it with absolute ethanol to obtain a 4mg / ml borneol ethanol solution. At the same time, take 10mg of TC@PLGA / NPs, put it in a 10ml volumetric flask, and dissolve it with distilled water to get For the drug-loaded nan...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses medicine for treating AD (alzheimer's diseases) and a preparation method thereof. The medicine is prepared from the following ingredients in percentage by mass: 15 percent of borneol, 4 percent of tanshinone IIA, 4 percent of cryptotanshinone and 77 percent of PLGA polymers. The invention also discloses a preparation method of the medicine for treating the alzheimer's diseases. Medicine carrying nanoparticles are combined with the borneol to be used; the BBB can be reversibly developed; the medicine concentration in the brain is improved; the AD treatment effect is improved. Fat-soluble ingredients TanIIA and CTan in radix salviae miltiorrhizae are used as model medicine for preparing polymer medicine carrying nanoparticles for treating the AD; the multi-target combined intervention treatment can be performed on the AD. Polylactic acid-glycolic acid (PLGA) is used as a nanometer material for wrapping the model medicine; the advantages of realizing the biodegradability, improving the bioavailability, enhancing the targeting performance and the like are realized; huge application potential is shown in the aspect of medicine release carriers.

Description

technical field [0001] The invention belongs to the technical field of new drug delivery system of traditional Chinese medicine, and relates to a medicine for treating Alzheimer's disease and a preparation method thereof, in particular, to a combination of borneol combined with salvia miltiorrhiza effective group for treating Alzheimer's disease Co-loaded polymer nanoparticles and a preparation method thereof. Background technique [0002] Alzheimer's disease (AD), also known as senile dementia, is by far the most common degenerative disease of the central nervous system. At present, there are nearly 30 million people in the world suffering from AD, and my country accounts for about a quarter. It has become one of the diseases with the highest incidence among the elderly population, seriously endangering the health of the elderly, and bringing a huge burden to society and families. The etiology of AD is complex, and the pathogenesis is still unclear. Currently, there are ma...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/045A61K31/58A61K9/51A61K47/34A61K47/32A61P25/28
CPCA61K9/5138A61K9/5153A61K31/045A61K31/58A61P25/28A61K2300/00
Inventor 邹亮章津铭王迪李维代丽萍卓虹伊
Owner CHENGDU UNIV